Dentsply Sirona

The Dentsply Sirona (Nasdaq:XRAY) board’s audit committee continues to work with independent counsel and advisors to investigate potentially questionable financial practices.

The Charlotte, North Carolina–based dental products and technologies company announced yesterday that it is still unable to file official quarterly reports. It’s notified the Nasdaq markets that it cannot meet a previously agreed upon Aug. 14, 2022 deadline to file the reports and is seeking another extension until Nov. 7 to file.

Dentsply Sirona said it expects to report Q2 revenues greater than $1.005 billion; The Street is expecting $1.01 billion.

The company also expects diluted EPS at or above 26¢ and adjusted EPS at or above 60¢.

U.S. dealer inventory levels are normalizing, and recent product launches and pricing adjustments are providing additional benefits, the company said in a news release. On the flip side, Dentsply Sirona experienced ongoing supply sh…

Dentsply Sirona (Nasdaq: XRAY) said today that it has entered into an accelerated share repurchase agreement with Bank of America, National Association to repurchase $150 million of its common stock.

The agreement will be completed under Dentsply Sirona’s present share repurchase authorization.

The accelerated share repurchase agreement has Dentsply Sirona initially receiving delivery of roughly 2.4 million shares.

The final number of shares repurchased will be based on the average daily volume-weighted average stock prices of the company’s common stock during the valuation period of the agreement, less a discount and subject to adjustments.

The final settlement of the accelerated share repurchase agreement is expected to be completed before the end of Q2 2022, subject to acceleration.

Dentsply Sirona (Charlotte, North Carolina) is a major manufacturer of professional dental products and technologies.

Dentsply Sirona (NDSQ:XRAY) shares dipped this morning on fourth-quarter results that came up shy of the consensus forecast.

XRAY shares were down 7.3% at $54.40 per share in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down 0.5%.

The Charlotte, North Carolina-based company posted profits of $102 million, or 47¢ per share, on sales totaling just shy of $1.1 billion for the three months ended Dec. 31, 2021, for a 3% bottom-line gain on sales growth of 0.5%.

Adjusted to exclude one-time items, earnings per share were 76¢, 3¢ behind expectations on Wall Street, where analysts were looking for sales of $1.13 billion.

“We are optimistic about our future,” Dentsply Sirona CEO Don Casey said in a news release. “We have a healthy innovation pipeline, a well-positioned portfolio, and new strategic partnerships to accelerate our growth.…

Dentsply Sirona (NSDQ:XRAY) posted third-quarter results this week that beat the overall consensus on Wall Street.

The Charlotte, N.C.-based company reported profits of $103 million, or 47¢ per share, on sales of $1.07 billion for the three months ended September 30, for a bottom-line gain of 94.3% on sales growth of 19.44% compared with Q3 2020.

Adjusted to exclude one-time items, earnings per share were 68¢, 3¢ ahead of The Street where analysts were looking for sales of $1.03 billion.

“In the third quarter, we delivered strong results in an environment still impacted by the pandemic. Organic sales grew over 21%, driven by continued recovery in the dental market and robust demand from our recent product launches. Our teams have also done a commendable job navigating supply chain bottlenecks to deliver products to our customers,” CEO Don Casey said in a news release. “In the quarter, we continued to accelerate investments in new products and…

Dentsply Sirona (NSDQ:XRAY) posted second-quarter results today that beat the overall consensus on Wall Street.

The Charlotte, N.C.-based company reported profits of $99 million, or 45¢ per share, on sales of $1.07 billion for the three months ended June 30 for a sales growth of 117.31% compared with Q2 2020.

Adjusted to exclude one-time items, earnings per share were 71¢, 6¢ ahead of The Street, where analysts were looking for sales of $1.01 billion.

“Our second-quarter performance closes out a strong first half of the fiscal year,” CEO Don Casey said in a news release. “Our financial results reflect the resilience of the dental market and demonstrate our team’s ability to execute operationally and financially. As we turn our attention to investing for future growth, we are confident that the underlying fundamentals of our business are strong and that we are well-positioned. Additionally, we remain committed to completing our restructu…

Dentsply Sirona (NSDQ:XRAY) posted first-quarter results today that beat the overall consensus on Wall Street.

The Charlotte, N.C.-based company reported profits of $117 million, or 53¢ per share, on sales of $1.027 billion for the three months ended March 31, for a sales growth of 17.5% compared with Q1 2020.

Adjusted to exclude one-time items, earnings per share were 72¢, 16¢ ahead of The Street, where analysts were looking for sales of $948.7 million.

“We are pleased with our strong first-quarter performance. The global dental market has demonstrated resilience with attractive underlying fundamentals. As a result, we are cautiously optimistic about the continued recovery in the category. We remain committed to executing on our restructuring goals while increasing focus on investing for revenue growth. Our revised 2021 outlook reflects confidence in our team’s ability to execute on growth initiatives and capitalize on the recovery,” CEO Don…